3.48
+0.13(+3.88%)
Currency In USD
Previous Close | 3.35 |
Open | 3.41 |
Day High | 3.67 |
Day Low | 3.07 |
52-Week High | 8.6 |
52-Week Low | 1.71 |
Volume | 508,605 |
Average Volume | 845,078 |
Market Cap | 9.6M |
PE | -0.41 |
EPS | -8.4 |
Moving Average 50 Days | 4.07 |
Moving Average 200 Days | 3.27 |
Change | 0.13 |
If you invested $1000 in Sintx Technologies, Inc. (SINT) 10 years ago, it would be worth $0 as of October 21, 2025 at a share price of $3.48. Whereas If you bought $1000 worth of Sintx Technologies, Inc. (SINT) shares 5 years ago, it would be worth $0.1 as of October 21, 2025 at a share price of $3.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ce
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
GlobeNewswire Inc.
Oct 16, 2025 11:00 AM GMT
New U.S. Patent reinforces competitive advantage and enables broader licensing and product opportunities across key markets SALT LAKE CITY, Utah, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”),
SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics
GlobeNewswire Inc.
Oct 14, 2025 11:00 AM GMT
New method patent expands SINTX’s infection-prevention IP portfolio in $30 Billion Total Addressable Market U.S. Patent Notice of Allowance reinforces competitive advantage and enables broader licensing and product opportunities across key markets SA